A photo of Christopher Siracusa.

Associate Director, Cystic Fibrosis Center

Assistant Professor, UC Department of Pediatrics

513-636-6771

Board Certified

About Me

Academic Affiliation

Assistant Professor, UC Department of Pediatrics

Divisions

Pulmonary Medicine, Cystic Fibrosis

My Locations

My Education

MD: American University of the Caribbean, Netherlands, Antilles, 2009.

Residency: Akron Children’s Hospital/NEOUCOM, Akron, OH, 2012.

My Publications

Acute Respiratory Distress Syndrome immediately following the removal of an aspirated foreign body. Simpson, R; Myer IV, C; Siracusa, C. Respiratory Medicine Case Reports. 2020; 29:100978-100978.

Reduction of Recurrence Risk of Pancreatitis in Cystic Fibrosis with Ivacaftor: Case Series. Carrion, A; Borowitz, DS; Freedman, SD; Siracusa, CM; Goralski, JL; Hadjiliadis, D; Srinivasan, S; Stokes, DC. Journal of Pediatric Gastroenterology and Nutrition. 2018; 66:451-454.

CFTR Modulator Therapies in Cystic Fibrosis. Spielberg, DR; Clancy, JP; Siracusa, C. TREATMENT OF CYSTIC FIBROSIS AND OTHER RARE LUNG DISEASES. : Springer Basel; Springer Basel; 2017.

Non-typeable Haemophilus influenzae purulent pericarditis in a child with cystic fibrosis. Downes, KJ; Abulebda, K; Siracusa, C; Moore, R; Staat, MA; Poynter, SE. Pediatrics International. 2016; 58:607-609.

Update in Pediatric Lung Disease 2014. Siracusa, CM; Brewington, JJ; Brockbank, JC; Guilbert, TW. American Journal of Respiratory and Critical Care Medicine. 2015; 192:918-923.

Electronic monitoring reveals highly variable adherence patterns in patients prescribed ivacaftor. Siracusa, CM; Ryan, J; Burns, L; Wang, Y; Zhang, N; Clancy, JP; Drotar, D. Journal of Cystic Fibrosis. 2015; 14:621-626.

Adherence Determinants in Cystic Fibrosis: Cluster Analysis o f Parental Psychosocial, Religious, and/or Spiritual Factors. Grossoehme, DH; Szczesniak, RD; Britton, LL; Siracusa, CM; Quittner, AL; Chini, BA; Dimitriou, SM; Seid, M. Annals of the American Thoracic Society. 2015; 12:838-846.